Microbot Medical Inc.
MBOT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000883975
No open-market purchases or sales by Microbot Medical Inc. insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $22.1M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Microbot Medical Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 68 | 3 | 71 | +6 |
| Shares | 8.97M | 39.2K | 11.4M | +2.46M (+27.6%) |
| Value | $27.4M | $119.6K | $22.8M | −$4.46M (−16.4%) |
3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Microbot Medical Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| 683 Capital Management, LLC | 256,033 | $512.1K | 0.04% |
| AlphaCentric Advisors LLC | 200,000 | $400.0K | 0.40% |
| Omers Administration Corp | 146,000 | $292.0K | 0.00% |
| Qube Research & Technologies Ltd | 131,696 | $263.4K | 0.00% |
| Bridgeway Capital Management, LLC | 111,000 | $222.0K | 0.00% |
| Virtu Financial LLC | 58,674 | $117.0K | 0.00% |
| Lighthouse Investment Partners, LLC | 41,100 | $82.2K | 0.00% |
| Goldman Sachs Group Inc | 34,463 | $68.9K | 0.00% |
| Caitong International Asset Management Co., Ltd | 32,596 | $65.2K | 0.02% |
| XTX Topco Ltd | 31,389 | $62.8K | 0.00% |
| Renaissance Technologies LLC | 24,560 | $49.1K | 0.00% |
| Invesco Ltd. | 24,512 | $49.0K | 0.00% |
| Man Group plc | 17,424 | $34.8K | 0.00% |
| Quantbot Technologies LP | 13,683 | $27.4K | 0.00% |
| StoneX Group Inc. | 12,046 | $24.1K | 0.00% |
| Citigroup Inc | 4,866 | $9.73K | 0.00% |
| Clearstead Advisors, LLC | 275 | $550 | 0.00% |
| SHP Wealth Management | 50 | $100 | 0.00% |
| Harbour Investments, Inc. | 1 | $2 | 0.00% |
Sold out (13)
Institutions that held Microbot Medical Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Heights Capital Management, Inc | 883,104 | $2.69M |
| EAM Investors, LLC | 207,322 | $632.3K |
| EHP Funds Inc. | 25,445 | $77.6K |
| Group One Trading, L.P. | 18,625 | $56.8K |
| Oxford Asset Management LLP | 17,694 | $54.0K |
| Wexford Capital LP | 16,276 | $49.6K |
| National Bank of Canada | 13,500 | $41.2K |
| Foundations Investment Advisors, LLC | 12,500 | $38.1K |
| SLT Holdings LLC | 12,500 | $38.1K |
| Zacks Investment Management | 10,683 | $32.6K |
| Ameritas Advisory Services, LLC | 1,186 | $3.62K |
| Wealthspire Advisors, LLC | 1 | $3 |
| Hilltop National Bank | 1 | $3 |
Not filed for Q4 2025 yet (3)
Institutions that held Microbot Medical Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Cubist Systematic Strategies, LLC | 38,985 | $118.9K |
| Point72 (DIFC) Ltd | 244 | $744 |
| Hemington Wealth Management | 1 | $0 |